Essential Insights
The three most important challenges to overcome for cell and gene therapy success
A closer look at the new challenges biopharmaceutical companies may encounter as they navigate the evolving cell and gene therapy market—and some promising solutions.
3 key insights from oncologists on emerging therapies
Recent medical advancements may change cancer care. New research explores oncologists' views on CAR T-Cell therapy, biosimilars and AML therapies.
New research: 3 key insights from oncologists
Oncology care has never been more complex. Our recent research provides deeper insights into how important issues are viewed by providers nationally.
Bringing precision medicine into focus
Precision medicine is an emerging approach for disease treatment. Our experts look at where it currently stands and what’s on the horizon.
Thank you for connecting with us.
Managing the complexity of outpatient oncology care
Approximately 1.8 million new cancer cases are detected annually, and the majority of cancer patients remain alive five years after diagnosis, underscoring the need for proper coordination of care.
Latest specialty care research
Latest findings on specialty care using real-world data
Value-based care and HEOR
Why manufacturers should leverage economics outcomes research to provide real-world evidence of the total value their specialty medications can deliver.
Emperor of all maladies
Dr. Bruce Feinberg’s take on Cancer: Emperor of all maladies
Is the third time the charm?
Exploring the issues that are impacting stakeholder adoption of Immuno-Oncology